Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026)
Beta Bionics' (BBNX) quarterly Asset Utilization Ratio came in at 0.4 in Q2 2026, up 70.73% year-over-year from 0.23 in Q2 2025, and up 14.54% quarter-over-quarter from 0.35 in Q1 2026.
Powered by 
Analysis
Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.4 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 70.73% year-over-year to 0.4; the TTM figure through Jun 2026 stood at 0.4 (up 70.73% YoY), while the FY2025 annual figure was 0.42, down 16.44% from the prior year.
- Asset Utilization Ratio came in at 0.4 for Q2 2026 at Beta Bionics, up from 0.35 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.4 in Q2 2026 to a low of 0.23 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.56 |
| 10 | Beta Bionics | 786.45 Mn | 605.96 Mn | 18.90 Mn | 0.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.29 |